Birth defect rates in women using Adalimumab (Humira) and intravenous immunoglobulin to treat immunologic-based infertility in IVF
E.E. Winger, J.L. Reed, S. Ashoush, S. Ahuja, J. Jadhav, T. El-Toukhy, M. TaranissiVolume:
81
Year:
2009
Language:
english
Pages:
2
DOI:
10.1016/j.jri.2009.06.243
File:
PDF, 76 KB
english, 2009